These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 8080393)

  • 21. The clinimetrics of hypokinesia in Parkinson's disease: subjective versus objective assessment.
    van Hilten JJ; Hoff JI; Middelkoop HA; Roos RA
    J Neural Transm Park Dis Dement Sect; 1994; 8(1-2):117-21. PubMed ID: 7893373
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Night-time sleep in Parkinson's disease - the potential use of Parkinson's KinetiGraph: a prospective comparative study.
    Klingelhoefer L; Rizos A; Sauerbier A; McGregor S; Martinez-Martin P; Reichmann H; Horne M; Chaudhuri KR
    Eur J Neurol; 2016 Aug; 23(8):1275-88. PubMed ID: 27160044
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sleep disruption, daytime somnolence and 'sleep attacks' in Parkinson's disease: a clinical survey in PD patients and age-matched healthy volunteers.
    Ferreira JJ; Desboeuf K; Galitzky M; Thalamas C; Brefel-Courbon C; Fabre N; Senard JM; Montastruc JL; Sampaio C; Rascol O
    Eur J Neurol; 2006 Mar; 13(3):209-14. PubMed ID: 16618334
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sleep improvement with levodopa/carbidopa intestinal gel infusion in Parkinson disease.
    Zibetti M; Rizzone M; Merola A; Angrisano S; Rizzi L; Montanaro E; Cicolin A; Lopiano L
    Acta Neurol Scand; 2013 May; 127(5):e28-32. PubMed ID: 23311399
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Plasma homocysteine level and its relationship to clinical profile in Parkinson's disease patients at the Lagos University Teaching Hospital.
    Ojo OO; Oladipo OO; Ojini FI; Sanya EO; Danesi MA; Okubadejo NU
    West Afr J Med; 2011; 30(5):319-24. PubMed ID: 22752818
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sleep disorder related to Parkinson's disease.
    Partinen M
    J Neurol; 1997 Apr; 244(4 Suppl 1):S3-6. PubMed ID: 9112582
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Demographic and motor features associated with the occurrence of neuropsychiatric and sleep complications of Parkinson's disease.
    Munhoz RP; Teive HA; Eleftherohorinou H; Coin LJ; Lees AJ; Silveira-Moriyama L
    J Neurol Neurosurg Psychiatry; 2013 Aug; 84(8):883-7. PubMed ID: 23463867
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nonmotor symptoms evolution during 24 months of bilateral subthalamic stimulation in Parkinson's disease.
    Dafsari HS; Silverdale M; Strack M; Rizos A; Ashkan K; Mahlstedt P; Sachse L; Steffen J; Dembek TA; Visser-Vandewalle V; Evans J; Antonini A; Martinez-Martin P; Ray-Chaudhuri K; Timmermann L;
    Mov Disord; 2018 Mar; 33(3):421-430. PubMed ID: 29465787
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Achieving 24-hour control of Parkinson's disease symptoms: use of objective measures to improve nocturnal disability.
    Chaudhuri KR; Pal S; Bridgman K; Trenkwalder C
    Eur Neurol; 2001; 46 Suppl 1():3-10. PubMed ID: 11741097
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Study of associated clinical variables and phenomenology of hallucinations in Parkinson's].
    Cubo E; González M; Aguilar A; Quintana S
    Neurologia; 2006; 21(1):12-8. PubMed ID: 16525921
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rotigotine transdermal patch in combination therapy for Parkinson's disease--observations in routine clinical practice.
    Ceballos-Baumann A; Häck HJ
    Curr Med Res Opin; 2011 Oct; 27(10):1899-905. PubMed ID: 21867400
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Time structure of leg movement activity during sleep in untreated Parkinson disease and effects of dopaminergic treatment.
    Puligheddu M; Figorilli M; Aricò D; Raggi A; Marrosu F; Ferri R
    Sleep Med; 2014 Jul; 15(7):816-24. PubMed ID: 24891077
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pramipexole vs levodopa as initial treatment for Parkinson disease: A randomized controlled trial. Parkinson Study Group.
    Parkinson Study Group
    JAMA; 2000 Oct; 284(15):1931-8. PubMed ID: 11035889
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Subthalamic nucleus stimulation for Parkinson disease: benefits observed in levodopa-intolerant patients.
    Katayama Y; Kasai M; Oshima H; Fukaya C; Yamamoto T; Ogawa K; Mizutani T
    J Neurosurg; 2001 Aug; 95(2):213-21. PubMed ID: 11780890
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dietary habits and neurological features of Parkinson's disease patients: Implications for practice.
    Barichella M; Cereda E; Cassani E; Pinelli G; Iorio L; Ferri V; Privitera G; Pasqua M; Valentino A; Monajemi F; Caronni S; Lignola C; Pusani C; Bolliri C; Faierman SA; Lubisco A; Frazzitta G; Petroni ML; Pezzoli G
    Clin Nutr; 2017 Aug; 36(4):1054-1061. PubMed ID: 27406858
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bromocriptine versus levodopa in early Parkinson's disease.
    Ramaker C; van Hilten JJ
    Cochrane Database Syst Rev; 2000; (3):CD002258. PubMed ID: 10908538
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Levodopa/carbidopa microtablets in Parkinson's disease: a study of pharmacokinetics and blinded motor assessment.
    Senek M; Aquilonius SM; Askmark H; Bergquist F; Constantinescu R; Ericsson A; Lycke S; Medvedev A; Memedi M; Ohlsson F; Spira J; Westin J; Nyholm D
    Eur J Clin Pharmacol; 2017 May; 73(5):563-571. PubMed ID: 28101657
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of cabergoline added to levodopa treatment on sleep-wake cycle in idiopathic Parkinson's disease: an open label 24-hour polysomnographic study.
    Romigi A; Stanzione P; Marciani MG; Izzi F; Placidi F; Cervellino A; Giacomini P; Brusa L; Grossi K; Pierantozzi M
    J Neural Transm (Vienna); 2006 Dec; 113(12):1909-13. PubMed ID: 16736238
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sleep quality in Parkinson disease: an examination of clinical variables.
    Stavitsky K; Cronin-Golomb A
    Cogn Behav Neurol; 2011 Jun; 24(2):43-9. PubMed ID: 21537164
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of cabergoline on sleep, periodic leg movements in sleep, and early morning motor function in patients with Parkinson's disease.
    Högl B; Rothdach A; Wetter TC; Trenkwalder C
    Neuropsychopharmacology; 2003 Oct; 28(10):1866-70. PubMed ID: 12865895
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.